Pinto Luciano Ribeiro, Alves Rosana Cardoso, Caixeta Eliazor, Fontenelle John Araujo, Bacellar Andrea, Poyares Dalva, Aloe Flavio, Rizzo Geraldo, Minhoto Gisele, Bittencourt Lia Rita, Ataide Luiz, Assis Márcia, Pradella-Hallinan Márcia, Pinto Maria Christina Ribeiro, Rodrigues Raimundo Nonato D, Hasan Rosa, Fonseca Ronaldo, Tavares Stella
Brazilian Sleep Association, São Paulo, SP, Brazil.
Arq Neuropsiquiatr. 2010 Aug;68(4):666-75. doi: 10.1590/s0004-282x2010000400038.
The Brazilian Sleep Association brought together specialists in sleep medicine, in order to develop new guidelines on the diagnosis and treatment of insomnias. The following subjects were discussed: concepts, clinical and psychosocial evaluations, recommendations for polysomnography, pharmacological treatment, behavioral and cognitive therapy, comorbidities and insomnia in children. Four levels of evidence were envisaged: standard, recommended, optional and not recommended. For diagnosing of insomnia, psychosocial and polysomnographic investigation were recommended. For non-pharmacological treatment, cognitive behavioral treatment was considered to be standard, while for pharmacological treatment, zolpidem was indicated as the standard drug because of its hypnotic profile, while zopiclone, trazodone and doxepin were recommended.
巴西睡眠协会召集了睡眠医学专家,以制定失眠症诊断和治疗的新指南。讨论了以下主题:概念、临床和社会心理评估、多导睡眠图检查建议、药物治疗、行为和认知疗法、合并症以及儿童失眠症。设想了四个证据级别:标准、推荐、可选择和不推荐。对于失眠症的诊断,建议进行社会心理和多导睡眠图检查。对于非药物治疗,认知行为疗法被视为标准疗法,而对于药物治疗,由于唑吡坦的催眠特性,它被指定为标准药物,同时佐匹克隆、曲唑酮和多塞平也被推荐。